Fulcrum Therapeutics Inc. (FULC) Earnings
|
Expand Research on FULC
| Next EPS Date | 7/29/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +0.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/30/26  |
Q126 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 2/24/26 |
Q425 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 10/29/25 | Q325 | -$0.31 | -$0.29 | -$0.02 | N/A | N/A | N/A |  | | Details | |
| 7/29/25 |
Q225 | -$0.28 | -$0.29 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/1/25 | Q125 | -$0.28 | -$0.26 | -$0.02 | N/A | N/A | N/A | | | Details | |
| 2/25/25 |
Q424 | N/A | -$0.28 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/13/24 | Q324 | -$0.35 | -$0.40 | +$0.05 | N/A | N/A | N/A | | | Details | |
| 7/31/24 | Q224 | $0.87 | -$0.41 | +$1.28 | $80M | $1.78M | N/A | | | Details |
